Kursprognose für Scholar Rock Holding Corp (SRRK)SRRKScholar Rock Holding Corp

Alphio's SRRK stock price prediction model matches the current Scholar Rock Holding Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $40.20 (-0.09%). The 1-week path is $39.75 (-1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Scholar Rock Holding Corp (SRRK) is currently not a strong buy due to its recent price decline and negative financial indicators. The current price is $39.90, with a 5-day change of -5.43% and a 20-day change of -14.47%. The RSI is at 24.002, indicating it is in oversold territory, which could suggest a potential rebound. However, the company has reported significant net losses, with a net income of -$109,896,000 in Q2 2026, and a forward P/E ratio of 0, indicating no earnings expectations. The main risk is the ongoing negative sentiment reflected in the stock's recent performance and the uncertainty around the uptake of its newly approved drug, ISEMBYLD, which has a market reaction that remains cautious. Therefore, while there are positive catalysts like FDA approval, the financial health and current price trends suggest holding off on new purchases for now.

Scholar Rock Holding Corp (SRRK) last closed at $40.24, gaining +0.85%. These facts feed the 1-day and 1-week SRRK price prediction above.